These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12544677)

  • 1. Visual function in menopause: the role of hormone replacement therapy.
    Guaschino S; Grimaldi E; Sartore A; Mugittu R; Mangino F; Bortoli P; Pensiero S; Vinciguerra A; Perissutti P
    Menopause; 2003; 10(1):53-7. PubMed ID: 12544677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
    Uncu G; Avci R; Uncu Y; Kaymaz C; Develioğlu O
    Gynecol Endocrinol; 2006 Sep; 22(9):501-5. PubMed ID: 17071534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the difference in histopathology and cell cycle kinetics among the postmenopausal endometrium treated with different progestins in sequential-combined hormone replacement therapy.
    Chang TC; Chen M; Lien YR; Chen RJ; Chow SN
    Menopause; 2003; 10(2):172-8. PubMed ID: 12627044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
    Schram JH; Boerrigter PJ; The TY
    Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women.
    Fletcher CD; Farish E; Dagen MM; Alazzawi F; McQueen D; Hart DM
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):339-42. PubMed ID: 2837887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow.
    Altintaş O; Caglar Y; Yüksel N; Demirci A; Karabaş L
    Ophthalmologica; 2004; 218(2):120-9. PubMed ID: 15004502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of hormone replacement therapy on dry eye syndromes evaluated by Schirmer test depend on patient age.
    Feng Y; Feng G; Peng S; Li H
    Cont Lens Anterior Eye; 2016 Apr; 39(2):124-7. PubMed ID: 26391390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of low-dose or standard-dose conjugated equine estrogen combined with different progesterone on bone density in menopause syndrome women].
    Zuo HL; Deng Y; Wang YF; Gao LL; Xue W; Zhu SY; Ma X; Sun AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):243-247. PubMed ID: 29747269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ocular changes after hormone replacement therapy in postmenopausal women. A preliminary report].
    Carranza Lira S; Jiménez AM; Olhovich I
    Ginecol Obstet Mex; 2005 Apr; 73(4):194-7. PubMed ID: 21966755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of the hormonal replacement therapy on the amount and stability of the tear film among peri- and postmenopausal women].
    Okoń A; Jurowski P; Goś R
    Klin Oczna; 2001; 103(4-6):177-81. PubMed ID: 11975013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding.
    Archer DF; Pickar JH
    Obstet Gynecol; 2000 Dec; 96(6):899-905. PubMed ID: 11084175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women.
    Hartmann B; Kirchengast S; Albrecht A; Laml T; Bikas D; Huber J
    Maturitas; 1995 Nov; 22(3):239-46. PubMed ID: 8746882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Genazzani AR
    Maturitas; 2003 Jul; 45(3):175-83. PubMed ID: 12818462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women.
    Proudler AJ; Cooper A; Whitehead M; Stevenson JC
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):30-5. PubMed ID: 12519409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women.
    Cengiz B; Atabekoglu C; Cetinkaya E; Cengiz SD
    Maturitas; 2003 Dec; 46(4):301-6. PubMed ID: 14625127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.
    Foster RH; Balfour JA
    Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients.
    Castelo-Branco C; Figueras F; Sanjuan A; Pons F; Vicente JJ; Vanrell JA
    Eur J Obstet Gynecol Reprod Biol; 1999 Apr; 83(2):207-11. PubMed ID: 10391534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C; Dinçer Cengiz S; Cengiz B; Akgün G
    Climacteric; 2006 Dec; 9(6):437-45. PubMed ID: 17085376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone.
    van der Mooren MJ; Demacker PN; Thomas CM; Borm GF; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1993 Dec; 52(2):117-23. PubMed ID: 8157140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.